4
Changes in Ownership
Lipocine Inc. Filed Acc 0001638599-19-001010
CEO and President sold 43,500 shares at $0.41 ($17,835)
- CEO and President acquired 145,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Mahesh V. CEO and President | 2019-12-04 | Option exercise | +145,000 | 952,112 | D | ||
| Patel Mahesh V. CEO and President | 2019-12-04 | Sale | −43,500 | $0.41 | $17,835 | 908,612 | D |
| Derivatives | |||||||
| Patel Mahesh V. CEO and President | 2019-12-04 | Option exercise · Restricted Stock Unit | −145,000 | 145,000 | D | ||
| Patel Mahesh V. CEO and President | 2019-12-05 | Grant or award · Restricted Stock Unit | +122,978 | 122,978 | D | ||
| Open-market sales · 43,500 sh · avg $0.41 · $17,835 | |||||||
Loading xslF345X03/doc4_6381.xml…